Kanamycin Sulfate Injection

26 October 2009

Products Affected - Description

Kanamycin sulfate 1 gram/3 mL vials (NDC 63323-0359-03), APP

Reason for the Shortage

APP is unable to obtain raw materials to manufacture kanamycin injection.

Estimated Resupply Dates

APP has kanamycin on long-term back order and the company estimates a release date of mid to late-2010. The company no longer has emergency stock available.

Related Shortages

• Aztreonam Injection
• Carbenicillin Indanyl Capsules— No Longer Available
• Cefaclor
• Cefazolin Injection— Resolved
• Cefepime Injection— Resolved
• Cefotetan Disodium— Resolved
• Cefotetan Injection— Resolved
• Cefoxitin Injection— Resolved
• Ceftizoxime Injection— Resolved
• Cefuroxime Injection— Resolved
• Ciprofloxacin Immediate-Release Tablets
• Doxycycline Hyclate Injection
• Erythromycin Lactobionate Injection
• Erythromycin Ophthalmic Ointment
• Imipenem and Cilastatin Injection— Resolved
• Kanamycin— Resolved
• Loracarbef Oral Tablets and Suspension— No Longer Available
• Minocycline Injection— No Longer Available
• Nafcillin Injection— Resolved
• Oxacillin Injection— Resolved
• Penicillin G Benzathine Injection— Resolved
• Penicillin G Procaine Suspension for Injection— Resolved
• Piperacillin and Tazobactam Injection— Resolved
• Polymyxin B Injection— Resolved
• Ticarcillin and Clavulanate Injection— Resolved
• Tigecycline Injection— Resolved
• Tobramycin Powder for Injection
• Vancomycin Hydrochloride Injection

Updated

October 26, 2009; September 14, 2009; August 7, 2009; July 7, 2009; May 20, 2009; May 12, 2009; February 26, 2009. University of Utah, Drug Information Service. Copyright 2009, Drug Information Service, University of Utah, Salt Lake City, UT.

Back to Drug Shortage Product Bulletins